PTPRC and neoplasm: p32 silenced B16F10 cells subcutaneous tumors showed decreased proliferation (Ki-67), angiogenesis (CD34), leukocyte (CD45), macrophage (F4/80) markers, and vimentin expression than control tumors (Fig. 4C) confirming its involvement with p32-mediated melanoma tumor progression.